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ABSTRACT: Surveillance systems include three fundamental elements of ongoing collection, 
analysis and feedback or dissemination of the data. A surveillance system for Hepatitis B was 
established in 1988 in order to improve prevention and control of transmission of this endemic 
disease. A disease register including data obtained mainly from notifications, laboratory reports 
and active case finding was established. This paper shows the findings from 1990 to 1993. The 
system shown cannot claim to be complete. However the findings suggest that some 14 clinically 
evident cases of Hepatitis B are confirmed each year. No rising trend has been seen. In anyone year 
a prevalence of 15.4 x 10.5 HBsAg positive results in persons who had previously not known that 
they were positive may be detected. Six month follow-up of these persons reveals that some 39 
persons become chronic carriers each year. This has implications both for the targeted vaccination 
programme as well as for the individual's chronic liver complications and treatment. 
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Introduction 
The French word 'surveillance' was introduced into 
English at the time of the Napoleonic wars and meant 
keeping close watch over an individual or group of 
individuals in order to detect any subversive tendencies. 
Assuming that disease is undesirable, if not subversive, 
this sinister overtone is appropriate for the association of 
the word surveillance to disease. Indeed the term 'police 
medicine' was applied to the form of public health 
surveillance, evolved by Johann Frank in Germany in 
1766 when he developed the concept of legal 
enforcement and a health care policy of legal 
enforcement l . 
The present concept of epidemiological surveillance 
emerged out of a system of rigid personal surveillance 
and sanitary control. The objective was to identify 
persons ill with a communicable disease, to isolate them 
and to take action to protect their entourage. In most 
countries this eventually led to a system of compulsory 
notification of communicable disease I. 
Those cases of hepatitis due to infection have been 
made notifiable through legal notices issued under the 
Prevention of Disease Ordinance and the Medical and 
Kindred Professions Ordinance, Chapter 31. However, 
this form of data collection is known to suffer from 
inconsistency, slowness of reporting, under-reporting 
and a heavy dependence on the personal initiative, 
motivation or individual enthusiasm of the notifying 
doctor (Figure 1). 
The frequency of infection with hepatitis B virus 
(HBY) and its mode of transmission varies in different 
Fig . 1 - Sources of data on HBV infection 
demonstrating under-infection (1990 to 1993). 
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Cases are picked up as notifications or as reports on 
'HBsAg positive' results from the virology laboratory. 
parts of the world. In Northern America, Central and 
Western Europe as well as in Australia, the incidence of 
Hepatitis S is relatively low. In these areas, only 0.1%­
0.5% of the population are hepatitis B surface antigen 
(HBsAg) carriers and these infections occur mainly in 
adults. In contrast in Asia, Africa and South America 
and the Pacific Islands, 5 to 15% of the residents are 
HBsAg carriers. The prevalence in Malta is thought to be 
similar to that of Western Europe though the carrier rate 
may be higher and is believed to be above 2%. 
HBY infection is known to be a major cause of acute 
and chronic liver damage, liver cirrhosis and primary 
hepatocellular carcinoma2• Moreover, one million 
Europeans are infected by Hepatitis B every year with 
estimates indicating that 90,000 will become chronic 
hepatitis carriers and 24,000 will die from the effects of 
chronic disease, cirrhosis and liver cancer3. This is six 
times the number reported in official statistics according 
to estimates by WH04. As yet, hepatocellular carcinoma 
is not such a common occurrence in Malta, there being 
only about three cases per year5 
In Malta, hepatitis has become one of the most 
frequently notified infectious diseases in the 1990s 
(Table 1). Hepatitis (all types) was the 7th most 
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Table 1 - Reported new cases of selected 
notifiable infectious diseases 
1 990 and 1993 
Infectious disease 
1990 Number of cases Rank 
Chicken Pox 679 I 
Whooping Cough 106 2 
Food Poisoning 77 3 
Murine typhus 48 4 
Leishmaniasis* 33 5 
Brucellosis 21 6 
Tuberculosis, Pulmonary 19 7 
Hepatitis A, Band 
non-A, non-B 19 7 
Infectious disease 
1993 Number of cases Rank 
Chicken Pox 363 I 
Food Poisoning 71 2 
Murine typhus 37 3 
Tuberculosis, Pulmonary; 22 4 
Hepatitis A, Band 
non-A, non-B 21 5 
Rubella** 16 6 
Dysentery, Bacillary 15 7 
* Only 7 cases 	of Leishmaniasis in 1993, hence ranked 
below top seven rankings 
** 	Rubella did not feature in top seven rankings in 1990 
as there were only 14 cases 
Source: Demographic Review of Maltese Islands, 1990 
and 1993 . Annual Reports 1990/93, Health 
Information Department 
frequently notified infectious disease in 1990 and moved 
up to the 5th place in 19936. An average of 22 new cases 
is notified annually. Of these, Hepatitis B is the most 
common - 60.67% (Table 2). This is known to be only a 
part of the true picture. Infections which are subacute or 
chronic (with no icteric course) are known to remain for 
the most part officially unreported2 (Figure 1). 
Method 
All notifications of hepatitis B are referred to the 
Superintendant of Public Health where they are 
registered and referred to the Medical Officers of Public 
Health (MOH) for investigation. These are based at the 
Disease Surveillance Branch of the Public Health 
Department. 
Another source of data is the medical djagnostic 
laboratories on the island, (in particular the Virology 
Department at St. Luke's Hospital). The laboratory based 
doctor is obliged by the Medical and Kindred 
Professions Ordinance (Chapter 31): "to give immediate 
notice to the Superintendent of Public Health any facts 
Table 2 - Contribution of Hepatitis B to total 
number of cases of Hepatitis notified 
Year Total no. Hepatitis A Hepatitis B Hepatitis 
of Hepatitis NANB* 
cases 
1990 19 6 10 3 
(5.27) ( 1.68) (2.80) (0.84) 
1991 22 3 18 I 
(6.11) (0.83) (5.0) (0.27) 
1992 27 14 12 I 
(7.43 ) (3.85) (3 .30) (0.27) 
1993 21 2 14 5 
(5.73) (0.54) (3.82) 0.36) 
( ) = rate x 10-5 
*NANB =Non A Non B 
Source: Demographic Review of Maltese Islands, 1990­
93. Infectious Disease Notifications, Public Health 
Department 
or circumstances touching the Public Health which may 
have come to his knowledge in the practice of his 
profession". This has always been interpreted as 
including any communicable disease laboratory results. 
The drug abusers with acute hepatitis B undergoing 
long term rehabilitation at St. Mary's Hospital, Luqa. are 
reported and the doctors based there take on the 
responsibility of ensuring that all contacts are screened 
and 	 offered immunisation. These patients are entered 
into this surveillance programme only when full 
notification is made by the hospital. Patients attending 
outpatient rehabilitation at the Detox centre, St. Luke's 
Hospital, on the other hand, are not entered into' 'the 
surveillance programme because of confidentiality - no 
personal details being available. 
The privately run Blood Bank at Floriana, which is 
complementary to the National Blood Transfusion 
Department at St. Luke's Hospital, notifies in confidence 
any 	 patients who are detected by their screening 
programme. In 1993 alone, out of 4,276 donors only two 
(0.05%) were found to be Hepatitis B positive. 
In the same year, out of 12,635 donations at the 
National Blood Transfusion Department. nine donors 
(0.071 %) were picked up. Despite the small percentage 
involved, it is unfortunate that in 1991, this Department 
decided to stop referring their positive donors to the 
Public Health Department for follow up advice. 
counselling and preventive measures such as 
immunisation of close contacts. The Public Health 
Department is no longer informed of Hepatitis cases 
detected at the National Blood Transfusion Department 
and therefore such cases are not investigated or offered 
immunisation along the same lines described in this 
article. 
After receiving the patient details, each MOH contacts 
the patient and with the help of a structured 
questionnaire, attempts to identify any risk factors or the 
possible source of infection. During this interview, 
I 
35 Surveillance of Hepatitis B in Malta - A four year trend 
l 
particular attention is given to the mode of transmission 
and to any potential direct (household) contacts. The 
MOH then, with the patient's consent, takes the 
opportunity to counsel the patient, his/her partner, and 
the remainder of the immediate family, answer any of 
their questions and educate them with regards to the 
precautions necessary to reduce the risk of transmission 
of the disease. A repeat HBsAg is taken to eliminate the 
possibility of a false positive result. Where indicated, 
HBeAg, anti-HBeAg, and anti-HBcAg may also be 
taken so as to obtain a clearer idea on the infectious/ 
immune state of the individual. The MOH will refer all 
contacts testing negative to the Floriana Health Centre 
for immunisation with I ml Engerix B and will follow 
them through the full course to prevent dropouts. Any 
contact testing positive is considered to be a new case in 
his/her own right and the procedure is reapplied to them 
and their own respective contacts. MOHs continue to 
offer their support, advice and other services to these 
persons should they be required. Once all this is done, 
the case is officially closed and the patient is advised to 
continue to go for regular clinical assessments at his GP 
or at the outpatients department if indicated. 
The data generated from each questionnaire is 
captured on a Disease Register and entered on a DBase 
IV programme situated at the Disease Surveillance 
Branch of the Public Health Department. Personal details 
including name, address, telephone number, ID, date of 
birth are entered as well as other details such as 
occupation, past medical, surgical and social history or 
any history of travel. Other possible risk factors are also 
entered in the register including, sexual contacts/ 
preference, history of IV drug abuse , etc. The type and 
onset of clinical features is also important. The direct 
family contacts are listed together with their ages and 
relationship to the patient under investigation. Personal 
details of these contacts are taken to enable them to be 
traced again should this become necessary in the future. 
All laboratory results of blood taken from contacts, as 
well as the dates of vaccination are recorded. Needless to 
say, this infornlation is regularly updated by the MOH 
and treated with absolute confidentiality at all times 
(passwords, locked discs). 
All persons with HBsAg are recommended to have a 
repeat test done six months later. For the purposes of this 
disease register, a chronic carrier is defined as a person 
with two positive HBsAg results six months apart. The 
number of cases investigated over the four year period 
by the Public Health Department can be noted in Table 3 
together wi th the resulting outcome of the investigations. 
Results and Discussion 
Assuming all notified cases to be symptomatic or 
icteric cases and all other unnotified laboratory reports to 
be asymptomatic (hence anicteric cases better referred to 
as subacute or chronic cases), Figure I shows the 
discrepancies between these two groups of patients. This 
is in keeping with reports from Northern Europe which 
suggest that there are an estimated three cases of 
anicteric Hepatitis B for every icteric case 7. 
The most commonly affected age is the 36-45 year 
group (Table 4). This differs from other published work 
in various parts of Europe which shows that in areas of 
low hepatitis B endemicity, the majority of infection 
Table 3 - Outcome of Hepatitis B cases 
investigated by the 
Public Health Department 
Year Acute Chronic Lost Deceased Total 
1990 5 46 5 I 57 
1991 9 44 7 I 61 
1992 5 31 7 3 46 
1993 7 34 14 4 59 
Source: Hepatitis B Register - Public Health 
Department. 
occurs in people aged 15-34 years, rising in the late teens 
to a peak in the twenties and then tailing of[8. 
Also, HBsAg positivity is found twice as commonly in 
males than in females (Figure 2). 
Table 4 - Age-sex distribution of HBsAg 
positive patients 
Age group Males No. Females No. Total No. 
(yrs) 
0- 15 4 II 15 
(0.88) (2.55) ( 1.70) 
16 - 25 10 10 20 
(3.87) (4.10) (3.98) 
26 - 35 32 14 46 
(\ 1.23) (5.13 ) (8.25) 
36 - 45 42 17 59 
(14.50) (5.91) (10.22) 
46 - 55 22 II 33 
(11.4) (5.32) (8.26) 
56 - 65 20 4 24 
(13.73) (2.28) (7.47) 
66+ 9 4 13 
(5.96) (1.98) (3.69) 
Total 139 71 210 
(7.82) (3.9) (5.84 ) 
Ratio: males to females 2: I 
Taking end 1991 population as denominator 
(Demographic Review 1991) 
( ) = Age specific rate x 10-4 
Source: Hepatitis B Register - Public Health Department 
Though the number of deaths in Hepatitis B patients as 
seen in Table 3 may seem to be significant , official 
statistics registered at the Health Information 
Department show that mortality from Hepatitis 8 as a 
primary cause is rare. Only one case was registered as 
having Hepatitis B as the primary cause of death (see 
Table 5). 
Modes of transmission 
The leading risk for transmission 111 developed 
countries is multiple partner sexual activity. 
36 L. Licari, A. J. Amato-Gauci 
Fig. 2 - All persons with HBsAg positive result 
35% 
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Unfortunately this is not an area where much research 
has been carried out in our population, though it is 
undoubtedly the more significant risk factor. We tried to 
deternline probable modes of transmission from the data 
in the surveillance programme but the main difficulty 
was in validating the reliability of the data. 
When looking at the intravenous drug users (lVDU), 
from all patients attending the Detoxification Centre at 
St. Luke's Hospital screened from 1987 to mid 1994, 
only 2.75% of the 800 attenders were Hepatitis B 
positive, which does not make this a predominant mode 
of transmission of the disease on the island so far9. 
Unpublished data on Hepatitis C gives a completely 
different picture. Approximately 60% of IVDU patients 
attending the health services are believed to be Hepatitis 
C positive!o. 
Newborn infants of highly infectious carrier mothers 
are also known to run a 70-90% risk of developing 
hepatitis B infection and up to 85-90% chance of 
becoming a chronic carrier!!. However a local study 
done in 1993 which looked at almost 1000 attenders at 
the Antenatal Clinic at Karen Grech Hospital showed 
that less than I % were found to carry the hepatitis B 
marker!2 . 
Children are especially vulnerable and in infants the 
risk of infection per exposure is even greater, i.e. 10 - 15 
times that of the general population. It has been shown 
that within households with two or more children 
infected with hepatitis B, it is likely that child-to-child 
transmission may also occurll. This may in fact account 
for the transmission that is known to occur in 
institutions. 
A US study showed that in families where the parents 
were not hepatitis B carriers but one of the children was, 
25% of other children in that family had been infected 
with hepatitis B and these children with hepatitis Bare 
more likely to become carriers of the virus than adultsll. 
Universal vaccination of young adolescents is known 
to be difficult because it relies on administering three 
doses of vaccine to 10 - 12 year olds - a group in whom 
compliance is poor. Therefore, an easier alternative 
would be to introduce the vaccine in the routine 
childhood immunisation programme, as is being 
advocated by WHO. 
Studies carried out by WHO in Italy show that a 
regular sexual partner of a Hepatitis B carrier has an 18 ­
30% chance of infection while those living in the same 
house as, an HBY carrier have the same likelihood of 
infection as sexual partners. In fact, household contacts 
can have up to three times greater risk of infection with 
Hepatitis B than the general population13 . 
Analysis of this surveillance data on Hepatitis B cases 
shows that positive secondary cases in household 
Table 5 - Hepatitis mortality 1990-1993. Yearly 
mortality from HepatitiS B compared to non A non B 
(NANB) and AIDS. 
Year Hep B NANBHep AIDS 
1990 o o 2 
1991 o o 3 
1992 I o 5 
1993 o 2 2 
Source: Health Information Department 
contacts of a case are not an uncommon occurrence. 
Possible routes of transmission in household contacts are 
thought to be through spots of the carrier's blood on the 
towels or other surfaces coming into contact with 
microlesions on someone else's skin. Nail-scissors and 
razor blades may also contribute, as well as the sharing 
of intimate objects like toothbrushes 11. 
It is important to trace and immunise all direct 
household contacts and to prevent chronic infeclion with 
Hepatitis B virus in Malta. This demands a strict 
immunisation programme for all contacts. A selective 
policy of vaccinating only the high risk groups against 
Hepatitis B is known to be the most rational prevention 
strategy but it has been shown in some cases to be 
inadequate and of limited success? Only about two 
thirds of contacts accepted the vaccination, a situation 
which we would like to see improve (see Table 6). 
The Health Division is currently reviewing the 
Hepatitis B immunisation policy and a national 
campaign was planned to be initiated some time in 
1997,14 though details on how the programme will be 
run are still to be announced. WHO recommends that 
hepatitis B immunisation programmes should be 
considered in all population groups who have chronic 
carrier rates of hepatitis B virus of over 2%15 . Moreover 
when a carriage rate reaches 3%, WHO recommends that 
the Hepatitis B immunisation programme should be 
introduced as an integral part of existing childhood 
immunisation programmes with the individual being 
vaccinated as early as possible8. 
The main objective of any immunisation programme 
should be to prevent chronic carriage of Hepatitis B 
virus: "The evidence for an association between the 
Table 6 - Number of direct contacts vaccinated 
Year Persons Persons Percentage 
offered accepting acceptance 
immunisation immunisation 
1990 182 124 68.13 % 
1991 187 128 68.45% 
1992 138 103 74.64% 
1993 132 74 56.06% 
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carrier state of hepatitis B virus infection and 
hepatocellular carcinoma (liver cell cancer) is now 
sufficiently strong to justify the use of a vaccine against 
this infection as a means ofpreventing this cancer. 16" 
When any country considers whether to embark on an 
immunisation programme using HB vaccine, it must 
determine what the level of risk in that country is before 
committing extensive resources. Collecting systematic 
health and disease information is important since this 
forms the basis for the description of the health 
dynamics of populations 1. Surveillance systems also 
help to set priorities concerning health improvements 
and to introduce effective measures including disease 
control and prevention, immunisation and education 
programmes. 
Collation of data from different sources and from all 
over the country is fundamental since the success of any 
surveillance system depends greatly on the quality of 
data collected. Also quick, reliable and accurate analysis 
together with timely publication of results in an 
acceptable format is an <:.ea for future development to 
improve the.system I7 . 
Unfortunately, it is not possible to estimate the true 
incidence/prevalence in Malta, even with expensive 
special studies. The data in this registration system can 
never be complete although efforts to eliminate major 
gaps are finally working and improvements are being 
noticed. 
The gaps in this data are mainly due to non­
compliance to the Prevention of Disease Ordinance. It is 
therefore important that the responsibility for this system 
of notification and registration is accepted not only by 
the Government Departments involved, but also by the 
doctors who have a vital role to play through their 
obligation to notify. 
Finally, the vaccination schedule to be adopted 
nationally should be planned not only according to the 
carriage rate estimated by this and other studies, but also 
according to the delivery capacity of the health system in 
terms of human and financial resources 15. Perinatal 
transmISSIOn and death rate from liver disease 
attributable to chronic HBV infection do not seem to be 
decisive factors in the local context. 
Conclusion 
The data analysed in this surveillance programme is 
insufficient and has gaps that are dependant on a variety 
of sources. Whilst non-compliance to the law is a major 
factor, other problems such as "ownership" of data with 
reluctance in forwarding information from one branch to 
another is also an issue. Accurate prevalence and 
incidence studies are desirable, but these require 
expensive studies which would still only provide an 
estimate of the true picture. 
Despite the above deficiencies, this surveillance 
system shows that hepatitis is one of the most prevalent 
notifiable infectious diseases in Malta with 20-25 
infections annually. 60.67% of these are Hepatitis B with 
14 new clinical cases confirmed annually and 39 persons 
becoming chronic carries. It is twice as common in 
males and is believed to be mainly transmitted through 
household contact and unprotected sex. A programme of 
immunisation for household contacts already exists and 
runs smoothly through the Floriana Immunisation 
Centre. At present, an immunisation programme 
targeting 10-11 year olds is being planned to be launched 
in the immediate future. However this strategy should 
be revised and a national campaign of vaccination 
starting with childhood immunisation programmes 
should be considered. 
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